今日盘中，华检医疗（01931.HK）股价出现大幅下跌，跌幅高达5.16%，引发市场关注。
消息面上，华检医疗于9月1日早间发布公告，称公司拟收购国富量子（00290.HK）约18.48亿股股份，占其全部已发行股本的20.31%。交易对价约31.42亿港元，将通过华检医疗以每股9.69港元配发及发行3.24亿股新股份支付。交易完成后，华检医疗将成为国富量子的单一最大股东。
尽管公司表示此次收购是推进RWA（真实世界资产）交易所战略的关键一步，但投资者似乎对这一大手笔收购持谨慎态度。市场分析人士指出，股价下跌可能反映了投资者对收购价格、潜在的股权稀释以及短期内对公司财务状况的影响等方面的担忧。然而，从长远来看，这次战略合作是否能为华检医疗带来预期的协同效应，仍有待市场进一步观察和验证。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.